Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial. 2018

Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: ccather@mgh.harvard.edu.

Lifetime co-occurring substance use disorders are common at the time of presentation for treatment of a first episode of primary psychosis and persistent substance use disorder (SUD) leads to poorer outcomes. We assessed whether the NAVIGATE program, a coordinated specialty care service that includes optional substance abuse content reduced substance use compared to usual care in 404 individuals in the Recovery After Initial Schizophrenia Episode-Early Treatment Program (RAISE-ETP) study. Participants were randomized to two years of NAVIGATE (n = 223) or usual care (n = 181) and assessed monthly for substance use. At baseline, over one-half (51.7%) of the participants met criteria for a lifetime SUD, including over one-third with alcohol use disorder (36.4%) and with cannabis use disorder (34.7%). Contrary to our hypothesis, there was no treatment group by time interaction effect on days of self-reported substance use over the two-year follow-up. Participant exposure to the substance abuse component of the NAVIGATE program was low, suggesting that modifications to the program and training method for clinicians may be needed. Further research is needed to determine the most effective strategies for addressing substance use disorders in persons recovering from a first episode of psychosis.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings

Related Publications

Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
September 2011, Psychiatric services (Washington, D.C.),
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
April 2009, The Journal of clinical psychiatry,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
January 2014, Comprehensive psychiatry,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
December 2021, Schizophrenia research. Cognition,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
December 2007, The Journal of clinical psychiatry,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
January 2011, BMC psychiatry,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
November 2013, Schizophrenia bulletin,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
July 2021, International journal of environmental research and public health,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
August 2006, Acta psychiatrica Scandinavica,
Corinne Cather, and Mary F Brunette, and Kim T Mueser, and Steven F Babbin, and Robert Rosenheck, and Christoph U Correll, and Piper Kalos-Meyer
August 2013, Early intervention in psychiatry,
Copied contents to your clipboard!